StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / innoventric.com

Innoventric

Innoventric (innoventric.com): 6 changes recorded in its website history since December 2020. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. FundingBetween and

    Announced on its homepage: “B Round Innoventric Secures $28.5M in Series B Funding!”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagecurrent websiteHistorical capture not publicly availableLink to observation
  2. FundingBetween and

    Announced on its homepage: “B Round Innoventric Secures $28.5M in Series B Funding!”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. FundingBetween and

    Announced on its homepage: “& Events News October 2024 B Round Innoventric Secures $28.5M in Series B Funding!”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  4. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  5. HeadlineBetween and
    BeforeA SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITATION
    AfterWorld Leader in Cross-Caval Approach for TR Treatment

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  6. FundingBetween and

    Announced on its homepage: “& Events News October 2024 B Round Innoventric Secures $28.5M in Series B Funding!”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 1 December 2020

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITION

nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. January 2025 – November 2026 · 4 captures · latest observed messagingWorld Leader in Cross-Caval Approach for TR Treatment

    Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Our solution is designed with both the physician and patient in mind, offe

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 4 captures in this group
    • 6 January 2025 · World Leader in Cross-Caval Approach for TR Treatment archived page
    • 13 July 2025 · World Leader in Cross-Caval Approach for TR Treatment archived page
    • 12 July 2026 · World Leader in Cross-Caval Approach for TR Treatment archived page
    • 6 November 2026 · World Leader in Cross-Caval Approach for TR Treatment current websiteHistorical capture not publicly available
  2. December 2020 – January 2024 · 5 capturesA SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITATION

    nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases

    This wording observed 27 January 2024.

    archived page
    Inspect 5 captures in this group
    • 1 December 2020 · A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITION archived page
    • 5 January 2022 · A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITION archived page
    • 11 August 2022 · A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITION archived page
    • 26 September 2023 · A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITATION archived page
    • 27 January 2024 · A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITATION archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Innoventric highlights Series B funding and updated TR treatment focus

Innoventric’s site emphasizes its Series B funding and positions the company as a leader in cross-caval approaches for TR treatment, alongside adding a careers page. The Series B announcement appears consistently on the homepage across multiple later periods.

  • Between January 2024 and January 2025, Innoventric announced on its homepage that it “Secures $28.5M in Series B Funding!” and changed its homepage headline to “World Leader in Cross-Caval Approach for TR Treatment”, and added a careers page. [1][2][3]
  • Between January 2025 and July 2025, Innoventric continued to announce on its homepage that it “Secures $28.5M in Series B Funding!”. [4]
  • Between July 2025 and July 2026, the homepage still announced that Innoventric “Secures $28.5M in Series B Funding!”. [5]
  • Between July 2026 and November 2026, the homepage continued to state that Innoventric “Secures $28.5M in Series B Funding!”. [6]

Cite this record

StartupHistory, “Innoventric” company record, https://startuphistory.org/c/innoventric.com

Machine-readable: /c/innoventric.com.json. How changes are found: method.